Home » Newsletters » BioWorld Science

BioWorld Science

July 23, 2008

View Archived Issues

New antiinfective agents disclosed in recent Novartis patent

Recent patents describe new treatment options for cardiovascular diseases

Combined radiation therapy with GMX-1777 may be useful in head and neck cancer

Gamida-Cell enters agreement with Amgen for use of cytokines in manufacture of StemEx

Pain Therapeutics reports results from phase I clinical trial of melanin-binding antibody

Alnylam grants InterfeRx license to Calando for RNAi therapeutics

2008 highlights at Lorus Therapeutics

Gilead Sciences offers Q2 overview

Antisense presents an update on the company's activities

Combretastatin A4 safe and effective in patients with anaplastic thyroid cancer

Novel analgesic agents reported in recent patent literature

Rituximab plus IVIG effective in desensitization for kidney transplantation

Nanoparticle-mediated drug delivery suppresses metastasis in murine cancer models

GeneNews launches blood-based molecular colorectal cancer test, ColonSentry

BioMarin and Summit collaborate on Duchenne muscular dystrophy program

Living Cell Technologies reports clinical benefit with DiabeCell in diabetes trial

Opexa reports results from phase I/II extension study with Tovaxin in MS

NicOx completes enrollment in 2 phase I trials of naproxcinod in hypertensive OA patients

Cenix and Regulus enter research agreement for miRNA-targeted drug discovery

Cell Therapeutics to meet with FDA in September 2008 to discuss sBLA for Zevalin

Roche to acquire Mirus for USD 125 million

Amorfix and UBC enter Alzheimer's research collaboration based on SOD1 protein

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...